HC Wainwright reaffirmed their buy rating on shares of Entrada Therapeutics (NASDAQ:TRDA – Free Report) in a research report report published on Friday, Benzinga reports. They currently have a $25.00 price target on the stock. Entrada Therapeutics Stock Performance Entrada Therapeutics stock opened at $14.42 on Friday. Entrada Therapeutics has a fifty-two week low of […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) fell 6% on Monday . The company traded as low as $15.40 and last traded at $15.42. 19,255 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 73,412 shares. The stock had previously closed at $16.41. Wall Street Analyst Weigh […]
Research Analysts Issue Forecasts for Entrada Therapeutics, Inc s Q3 2023 Earnings (NASDAQ:TRDA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) insider Nerissa Kreher sold 10,348 shares of the firm’s stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $15.19, for a total transaction of $157,186.12. Following the completion of the sale, the insider now owns 27,130 shares in the […]
Entrada Therapeutics, Inc (NASDAQ:TRDA) Insider Nerissa Kreher Sells 6,898 Shares theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.